48,830
edits
Difference between revisions of "Rhabdomyosarcoma"
Jump to navigation
Jump to search
→IHC: fix sp.
m (→Electronmicroscopy: wikify) |
(→IHC: fix sp.) |
||
| Line 116: | Line 116: | ||
|} | |} | ||
A paper | A paper by Wachtel at al.<ref>{{cite journal |author=Wachtel M, Runge T, Leuschner I, ''et al.'' |title=Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry |journal=J. Clin. Oncol. |volume=24 |issue=5 |pages=816–22 |year=2006 |month=February |pmid=16391296 |doi=10.1200/JCO.2005.03.4934 |url=}}</ref> proposes the use of: | ||
* ''AP2beta'' and ''P-cadherin'' +ve in translocation positive alveolar RMS, and | * ''AP2beta'' and ''P-cadherin'' +ve in translocation positive alveolar RMS, and | ||
* ''EGFR'' and ''fibrillin-2'' +ve in embryonal RMS and translocation negative alveolar RMS. | * ''EGFR'' and ''fibrillin-2'' +ve in embryonal RMS and translocation negative alveolar RMS. | ||